Weight-loss drug developer Metsera reveals wider loss in US IPO filing
(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a U.S….
February 5, 2025
US proposes payment rate for 2026 Medicare Advantage insurers
(Reuters) – The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that…
US chicken, pork plant workers face higher health risks, USDA studies confirm
By Tom Polansek CHICAGO (Reuters) – Workers in U.S. chicken and pork plants face higher risks than other manufacturing workers…